Global X S&P Biotech ETF (ASX:CURE)

ASX:CURE Holdings Information

ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Moderna stock at 2.12%, Vaxcyte at 1.74%, Roivant Sciences at 1.70%, Mirum Pharmaceuticals at 1.63%, and Arcellx at 1.63%.

• Total Holdings: 10
• Top 10 Percentage: 16.37%
• Asset Class: Equity
• ETF Category: Health Care
• Assets: 40.69M
• PE Ratio: n/a

Top 25 Holdings

As of Feb 26, 2026

Filter results

No.	Symbol	Name	% Weight	Shares
1	MRNA	Moderna, Inc.	2.12%	11,969
2	PCVX	Vaxcyte, Inc.	1.74%	7,989
3	ROIV	Roivant Sciences Ltd.	1.70%	17,166
4	MIRM	Mirum Pharmaceuticals, Inc.	1.63%	4,357
5	ACLX	Arcellx, Inc.	1.63%	4,152
6	PRAX	Praxis Precision Medicines, Inc.	1.59%	1,328
7	RVMD	Revolution Medicines, Inc.	1.59%	4,461
8	AMGN	Amgen Inc.	1.46%	1,102
9	FOLD	Amicus Therapeutics, Inc.	1.46%	29,450
10	GILD	Gilead Sciences, Inc.	1.45%	2,863